Search results
Results from the WOW.Com Content Network
National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...
COVID-19 vaccine production by country Country Doses (millions) 3 Mar 2021 [1] 31 Jan 2022 [2] China 141.6: 4951.4 European Union 81.0:
New Zealand: 4,302,330 83.84% Republic of Ireland ... This template is used to provide data for COVID-19 vaccine, COVID-19 pandemic by country and territory, and ...
Main page; Contents; Current events; Random article; About Wikipedia; Contact us
In April 2020, it was reported that the UK agreed to work with 20 other countries and global organizations, including France, Germany, and Italy, to find a vaccine and share the results, and that UK citizens would not get preferential access to any new COVID‑19 vaccines developed by taxpayer-funded UK universities. [8]
On July 22, 2020, the U.S. government placed a conditional advance-purchase order of $2 billion with Pfizer to manufacture 100 million doses of a COVID-19 vaccine, with an option for 500 million more, for use in the United States if the vaccine was shown to be safe, effective, licensed, and authorized by the Food and Drug Administration (FDA).
NICs are countries whose economies have not yet reached a developed country's status but have, in a macroeconomic sense, outpaced their developing counterparts. Such countries are still considered developing nations and only differ from other developing nations in the rate at which an NIC's growth is much higher over a shorter allotted time period compared to other developing nations. [3]
Country-wise immunization profile from UNICEF; Data visualisation of immunization coverage; Regional immunization snapshots; Gavi Vaccine Alliance Immunuzation coverage; DPT immunization coverage at 1 year of age by country and year from WHO; Measles vaccine second dose coverage by nationally recommended age by country from WHO